Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
Rina-S Shows Durable Ovarian Cancer Responses as the Comparative Test Continues
New Phase I/II results show tumour responses in previously treated ovarian cancer. A randomized Phase III study addresses the harder question of benefit against other treatment.
-
Antora’s 5.8 GWh Heat Battery Deal Takes Industrial Storage Beyond the Pilot
A planned Kansas project will store electricity as heat for a biorefinery. The commercial contract matters as much as the carbon blocks, but delivery still lies ahead.
-
IBM’s Self-Hosted Bob Brings the AI Coding Agent Inside the Company’s Infrastructure
IBM now offers its software-development agent on customer-managed OpenShift infrastructure. The deployment choice adds control, but also shifts operational responsibility.
-
Singapore’s AI Cooling Testbed Is Bringing the Whole Data Centre Into the Experiment
Yokogawa has joined an NUS-led testbed expanding toward a multi-megawatt pilot. The project aims to test power, cooling and controls together in tropical conditions.
-
A Four-Hour Battery and a Wheatbelt Wind Farm Clear Australia’s Financing Hurdle
Atmos has reached financial close on Teebar battery storage and the Parron wind farm. The projects illustrate how generation, storage and revenue support fit together.
-
Human Stem-Cell Grafts Give Gene Editing a More Personal Test for Muscular Dystrophy
Scientists need dependable ways to test gene correction before human trials. An experimental model asks a crucial question: which version of a protein has returned?
-
A Major Cancer Blood-Test Trial Shows Why Finding More Cancer Is Only the First Test
New NHS-Galleri papers provide detailed results from 142,250 participants. The trial missed its main goal, even as it found signals worth following.
-
An Engineered Virus Shows a Promising but Uneven Signal Against Pancreatic Cancer
A Phase IIb study tested VCN-01 alongside chemotherapy. The new peer-reviewed report shows why its survival signal needs a larger confirming trial.
-
Fervo’s New Geothermal Plant Is Now Selling Power From Deep Underground
Cape Station’s first 33-megawatt unit has entered commercial operation. The milestone advances enhanced geothermal, while the rest of the project is still being built.
-
Novartis’s New RNA Deal Aims to Make an Immune Drug Inside the Body
Novartis is licensing an experimental RNA treatment that tells cells to make an immune-targeting protein. The agreement is significant, but the human evidence remains early.
-
AI Training Just Lost a Copyright Fight. The Ruling Has a Crucial Limit
A US appeals court has upheld Thomson Reuters’ win over Ross Intelligence. The dispute concerned a competing legal-search system, and its scope matters.
-
Queensland’s AI Power Debate Keeps Nuclear Out and Coal In
Queensland’s rejection of nuclear-powered data centres puts its existing energy roadmap under scrutiny. Reliability promises still need to be judged alongside delivery and emissions.